Type 2 diabetes: Complications and comorbidities

Owusu Adjah ES et al. Cardiovasc Diabetol 2018; 17: 70. doi: 10.1186/s12933-018-0712-1

Research shows that intensive blood pressure control increases the risk for new-onset chronic kidney disease, particularly in patients with type 2 diabetes, creating a potential treatment dilemma.

The excess mortality risk associated with high or very low glycated hemoglobin values is modified by glycemic variability in diabetes patients aged 70 years or more, shows an analysis of The Health Improvement Network database.

Adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin and sulfonylurea treatment may improve glycemic control in patients with type 2 diabetes and high cardiovascular risk, a post-hoc analysis of the EXAMINE trial suggests.

As the utility and availability of devices surges, so too do patient expectations. Advisory Board member Katharine Barnard provides key consultation questions to help determine your patients’ greatest needs and obstacles.

With the 2017 NaDIA results showing some positive trends in inpatient diabetes care, medwireNews talks to national clinical lead Gerry Rayman about the tools and tactics to deliver the best patient outcomes.

Data from the US NHANES show that a high proportion of adults with prediabetes also have cardiovascular and renal risk factors.

Experts review the evidence and best clinical practices of initiating and titrating insulin in patients with type 2 diabetes and provide guidance and practical recommendations for the healthcare community.

Awareness and education about compassion fatigue can help to limit its incidence and severity. Sanjay Kalra outlines strategies to identify and manage the emotional exhaustion that often affects diabetes caregivers.

This review takes a practical approach to the assessment, nursing care, and medical treatment of diabetes in the elderly, highlighting major challenges and suggesting solutions to common clinical problems.

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment.

Research shows that changes in markers of the metabolic syndrome and fatty liver disease are present more than 20 years before people receive a diagnosis of type 2 diabetes.

How would you diagnose and treat the third patient in our series of case studies on atypical forms of diabetes? Editorial board member Jay Shubrook challenges you.

Editorial Board member Sanjay Kalra shares his pragmatic and practical suggestions on initiating, monitoring, and titrating suitable patients on U500 regular insulin.

Editorial Board member Lori Berard addresses 2017's World Diabetes Day theme, providing her insights on the key considerations for managing diabetes in women (9:51).

Advisory Board member and pharmacist, Josh Neumiller, presents a practical guide to support clinical decision-making in the initiation and titration of U300 insulin glargine and insulin degludec.

Using a patient-centered care approach, the authors detail how to work in partnership with a patient to prevent hypoglycemia through evidence-based management of the disease and appropriate education.

This review provides an overview of the diagnosis and management of hypoactive sexual desire disorder, aiming to provide a practical approach to an under-recognized complication in women with diabetes.

Diabetes check-ups can be multifaceted and time-consuming. Editorial Board member and Family Physician, Jay Shubrook, presents his practical recommendations for making the most of your patient visits.